The VAI status indicates that there are no such complying issues with the facility; hence, the USFDA will not take any regulatory or administrative action against the facility.

OpenAI’s big rebranding effort brings a new logo and a new typeface, OpenAI sans. OpenAI’s big rebranding effort brings a new logo and a new typeface, OpenAI sans. Emma Roth is a news writer ...

The much-awaited route is nearing completion. Once operational, the expressway will significantly cut the travel time between Mumbai and Goa to just 6 hours. This will ease travel experience of ...

Maruti Swift price in Goa start at ₹ 6.49 Lakh. The lowest price model is Maruti Swift LXi and the top model price is Maruti Swift ZXi Plus AMT DT priced at ₹ 9.64 Lakh. Visit your nearest ...

"So far there was no system of having a company secretary and a chartered accountant in the finance department. For Sawant said the cabinet also approved the proposal for amendment to the Goa ...

and the US business aiding Cipla to register growth in FY26. “The US business should witness a gradual recovery from 1QFY26F, with the Lanreotide franchise’s supplies resuming. With the USFDA’s ...

Cipla has been helping extend the reach of affordable life-saving HIV/AIDS medications since 2001. The company supplies antiretroviral (ARV) medicines to 64 countries by mostly participating in the ...

Pharma major Cipla Ltd on Tuesday posted its highest-ever quarterly revenue and Ebitda margin, as robust sales in India, Europe and emerging markets outweighed weakness in its US business.

Cipla Ltd. has expressed optimism about exceeding its FY25 guidance, supported by strong operational performance and a focused strategy. The company stated that supply challenges related to Lanreotide ...

HYDERABAD/BENGALURU (Reuters) -Cipla, one of India's largest drugmakers by sales, reported a bigger-than-expected third-quarter profit on Tuesday helped by strong domestic demand, and said the U.S ...

Drug major Cipla reported a 49% year-on-year jump in its December quarter consolidated net profit, reaching Rs 1,571 crore, compared to Rs 1,056 crore in the same period last year. The profit after ...

Cipla Ltd.'s consolidated net profit rose 49% year-on-year in the third quarter of the current financial year, beating analysts' estimates by a substantial margin. The drugmaker posted a consolidated ...